Thus, TNF blocking carries a risk of inhibiting the activity of some suppressor cells, and we sometimes encounter exacerbation of autoimmune diseases such as psoriasis, lupus-like syndrome, multiple sclerosis, and sarcoidosis during anti-TNF treatment [53]. Here, TNF is linked to drug-induced lupus erythematosus.